Company Name, Ticker, Customers, else..

Quest Diagnostics Inc (DGX)

Other Ticker:

Sector • Healthcare Industry • Medical Laboratories

Industry • Medical Laboratories

Sector • Healthcare

Quest Diagnostics Inc

DGX's Fundamental analysis

Select the Comparisons :

None ▼

Select the Ratio:

None▼

None ▼

None▼

DGX Growth rates comparisons

Quest Diagnostics Inc's sales fell by -14.98 % in IV. Quarter 2022 from the same quarter a year ago. Ranking at No. 1933

Medical Laboratories industry recorded deterioration of revenues by -1.94 %

Quest Diagnostics Inc's net profit deacreased by -71.91 % in IV. Quarter 2022 year on year, to $116 millions.

• More on DGX's Growth

DGX's Valuation comparisons

Quest Diagnostics Inc
current PE on trailing twelve month basis is below Medical Laboratories industry average.

Quest Diagnostics Inc realized cash outflow of $ -4.69per share in trailing twelve-month period.

Company

17.67

PE TTM

Industry

19.5

PE TTM

Company's Price to Sales ratio is at 1.68.
Medical Laboratories industry's Price to Sales ratio is at 2.1.

• More on DGX's Valuation

Total Debt (Millions $)	3,980
Dividend TTM ($)	2.56 $
Dividend Yield TTM (%)	1.81 %
Revenue/Employee (TTM) $	201,694
Net Income/Employee (TTM) $	20,714
Receivable Turnover (TTM)	7.69
Tangible Book Value (Per Share $)	-20.07

DGX's Valuation comparisons

Quest Diagnostics Inc
current PE on trailing twelve month basis is below Medical Laboratories industry average.

Quest Diagnostics Inc realized cash outflow of $ -4.69per share in trailing twelve-month period.

Company

17.67

PE TTM

Industry

19.5

PE TTM

Company's Price to Sales ratio is at 1.68.
Medical Laboratories industry's Price to Sales ratio is at 2.1.

Quest Diagnostics Inc Price to Book Ratio is at 2.8 lower than Indusry Avg. of 351.05. and higher than S&P 500 Avg. of -0.01

• More on DGX's Valuation

• Market Capitalization (Millions $)	16,624
• Shares Outstanding (Millions)	119
• Employees	49,000
• Revenues (TTM) (Millions $)	9,883
• Net Income (TTM) (Millions $)	1,015
• Cash Flow (TTM) (Millions $)	-557
• Capital Exp. (TTM) (Millions $)	-404
• Total Debt (Millions $)	3,980
• Dividend TTM ($)	2.56 $
• Dividend Yield TTM (%)	1.81 %
• Revenue/Employee (TTM) $	201,694
• Net Income/Employee(TTM) $	20,714
• Receivable Turnover Ratio (TTM)	7.69
• Tangible Book Value (Per Share $)	-20.07

• Market Capitalization (Millions $)	16,624
• Shares Outstanding (Millions)	119
• Employees	49,000
• Revenues (TTM) (Millions $)	9,883
• Net Income (TTM) (Millions $)	1,015
• Cash Flow (TTM) (Millions $)	-557
• Capital Exp. (TTM) (Millions $)	-404

DGX's Profitability Comparisons

Quest Diagnostics Inc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in IV. Quarter 2022 to 5.79 % from 15.77 % in III. Quarter.

Quest Diagnostics Inc net profit margin of 4.97 % is currently ranking no. 9 in Medical Laboratories industry, ranking no. 150 in Healthcare sector and number 1723 in S&P 500.

Profitability by Segment
Clinical laboratory testing business	16.67 %
All other operating segments	25.86 %

	*Ratio*
• Capital Ratio (MRQ)	1.36
• Total Debt to Equity (MRQ)	0.67
• Tangible Leverage Ratio (MRQ)	-
• Asset Turnover Ratio (TTM)	0.74
• Inventory Turnover Ratio (TTM)	33.99

DGX's Profitability Comparisons

Quest Diagnostics Inc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in IV. Quarter 2022 to 5.79 % from 15.77 % in III. Quarter.

Quest Diagnostics Inc net profit margin of 4.97 % is currently ranking no. 9 in Medical Laboratories industry, ranking no. 150 in Healthcare sector and number 1723 in S&P 500.

• More on DGX's Key Ratios


Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar FHLBIN's Profile Stock Price FHLBIN's Financials Business Description Fundamentals Charts & Quotes FHLBIN's News Suppliers FHLBIN's Competitors Customers & Markets Economic Indicators FHLBIN's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071